Variant:
rs2115819 at chr10:45901089 in ALOX5 (VIP)

Alleles (on + chromosomal strand)
A > G
Alternate Names:
c.432-6550A>G, g.3546154A>G, g.36461A>G, rs2115819

Clinical Annotations

To see the clinical annotation for this variant please register or sign in.

Variant Annotations

PharmGKB variant annotations provide information about variant-drug pairs based on individual PubMed publications. Each annotation represents information from a single paper and the goal is to report the information that the author states, not an interpretation of the paper. The PMID for supporting PubMed publications is found in the "Evidence" field.

Information presented, including study size, allele frequencies and statistics is taken directly from the publication. However, if the author does not correct p-values in cases of multiple hypotheses, curators may apply a Bonferroni correction. Curators attempt to report study size based on the actual number of participants used for the calculation of the association statistics, so the number may vary slightly from what is reported in the abstract of the paper. OMB Race Category information is derived from the paper and mapped to standardized categories. Category definitions may be found by clicking on the "OMB Race Category" link.

There are 1 annotations for this variant. Register or sign in to see them.

There are 1 disease-related annotations for this variant. Register or sign in to see them.

VIP Variant in ALOX5

This is an intronic single nucleotide polymorphism (SNP) reported by Lima et al. which is positively associated with increased FEV 1 response to montelukast therapy. This SNP is also part of a 4-SNP haplotype associated with increased numbers of asthma exacerbations during 6 months of montelukast treatment relative to placebo [Article:16293801] (see Phenotype Dataset).

Key Publications:
Drugs / Other Molecules
Drug (1)
Diseases Asthma 1
Phenotype
Response to montelukast treatment in asthma 2
Phenotype Datasets Outcomes in Asthmatics taking montelukast

Connected Drugs

Evidence Drug
montelukast

Connected Diseases

Evidence Disease
Asthma

Publications related to rs2115819 at chr10:45901089: 1

Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. American journal of respiratory and critical care medicine. 2006. Lima John J, et al. [Article:16293801@PubMed]

Cross-References

UCSC Golden Path:
chr10:45901089
dbSNP:
rs2115819
ALFRED:
SI304256U
HapMap:
rs2115819

Platform Availability

  • Illumina

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.